{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:37Z","timestamp":1786985257884,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopha.2024.117469","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T20:08:31Z","timestamp":1727208511000},"page":"117469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification and preclinical evaluation of MMV676558 as a promising therapeutic candidate against Clostridioides difficile"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7736-7500","authenticated-orcid":false,"given":"Matthew","family":"Phanchana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-7278","authenticated-orcid":false,"given":"Methinee","family":"Pipatthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-1803","authenticated-orcid":false,"given":"Tanaporn","family":"Phetruen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattanai","family":"Konpetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattaneeya","family":"Prangthip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phurt","family":"Harnvoravongchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanakarn","family":"Sripong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sombat","family":"Singhakaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarawut","family":"Wongphayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surang","family":"Chankhamhaengdecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-5575","authenticated-orcid":false,"given":"Tavan","family":"Janvilisri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2024.117469_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jamainternmed.2016.0177","article-title":"Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C. difficile Infections: A Quasi-Experimental Controlled Study","volume":"176","author":"Longtin","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"42","key":"10.1016\/j.biopha.2024.117469_bib2","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.3748\/wjg.v27.i42.7210","article-title":"Frontiers in antibiotic alternatives for Clostridioides difficile infection","volume":"27","author":"Phanchana","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.biopha.2024.117469_bib3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-019-03539-6","article-title":"Clostridium difficile infection: review","volume":"38","author":"Czepiel","year":"2019","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117469_bib4","first-page":"2019","author":"CDC, Antibiotic Resistance Threats in the United States","year":"2019","journal-title":"Atlanta, GA"},{"issue":"1","key":"10.1016\/j.biopha.2024.117469_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/EBC20160062","article-title":"Insights into drug resistance mechanisms in Clostridium difficile","volume":"61","author":"Harnvoravongchai","year":"2017","journal-title":"Essays Biochem"},{"issue":"5","key":"10.1016\/j.biopha.2024.117469_bib6","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117469_bib7","unstructured":"Important Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms, 2019. https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/important-safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious-adverse. (Accessed September 13 2023)."},{"key":"10.1016\/j.biopha.2024.117469_bib8","unstructured":"Update to March 12, 2020 Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Events Likely Due to Transmission of Pathogenic Organisms, 2020. https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/update-march-12-2020-safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious. (Accessed September 13 2023)."},{"issue":"7","key":"10.1016\/j.biopha.2024.117469_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2024.117469_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biopha.2024.117469_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009384","article-title":"Actives from MMV Open Access Boxes? A suggested way forward","volume":"17","author":"Samby","year":"2021","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.biopha.2024.117469_bib12","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/S2666-5247(21)00326-8","article-title":"Searching for new therapeutic options for the uncommon pathogen Mycobacterium chimaera: an open drug discovery approach","volume":"3","author":"Cantillon","year":"2022","journal-title":"Lancet Microbe"},{"issue":"2","key":"10.1016\/j.biopha.2024.117469_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"issue":"3","key":"10.1016\/j.biopha.2024.117469_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/JB.01980-12","article-title":"Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile","volume":"195","author":"Ethapa","year":"2013","journal-title":"J. Bacteriol."},{"issue":"40","key":"10.1016\/j.biopha.2024.117469_bib15","doi-asserted-by":"crossref","first-page":"16169","DOI":"10.1073\/pnas.1311066110","article-title":"Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules","volume":"110","author":"Nonejuie","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2024.117469_bib16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3389\/fmicb.2019.00887","article-title":"Core Gut Bacteria Analysis of Healthy Mice","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2024.117469_bib17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2147\/DDDT.S244903","article-title":"Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture","volume":"14","author":"Tadele","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.117469_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52176-8","article-title":"Diaminoquinazoline MMV675968 from Pathogen Box inhibits Acinetobacter baumannii growth through targeting of dihydrofolate reductase","volume":"9","author":"Songsungthong","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2024.117469_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200600","article-title":"A Drug Repurposing Approach to Identify Therapeutics by Screening Pathogen Box Exploiting SARS-CoV-2 Main Protease","volume":"20","author":"Tyagi","year":"2023","journal-title":"Chem. Biodivers."},{"issue":"3","key":"10.1016\/j.biopha.2024.117469_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0014-4894(79)90094-8","article-title":"Plasmodium falciparum: Microaerophilic Requirements in Human Red Blood Cells","volume":"47","author":"Scheibel","year":"1979","journal-title":"Exp. Parasitol."},{"issue":"23","key":"10.1016\/j.biopha.2024.117469_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00320-17","article-title":"Anaerobic Mycobacterium tuberculosis Cell Death Stems from Intracellular Acidification Mitigated by the DosR Regulon","volume":"199","author":"Reichlen","year":"2017","journal-title":"J. Bacteriol."},{"issue":"5906","key":"10.1016\/j.biopha.2024.117469_bib22","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1164571","article-title":"3rd, PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117469_bib23","unstructured":"Centers for Disease Control and Prevention, Provisional CDC Guidance for the Use of Pretomanid as part of a Regimen [Bedaquiline, Pretomanid, and Linezolid (BPaL)] to Treat Drug-Resistant Tuberculosis Disease, 2024. \u3008https:\/\/www.cdc.gov\/tb\/topic\/drtb\/bpal\/default.htm\u3009. (Accessed 3 March 2024 2024)."},{"key":"10.1016\/j.biopha.2024.117469_bib24","unstructured":"WHO, WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, World Health Organization, Geneva, 2022."},{"issue":"6789","key":"10.1016\/j.biopha.2024.117469_bib25","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/35016103","article-title":"A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis","volume":"405","author":"Stover","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2024.117469_bib26","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1038\/s41598-018-23110-1","article-title":"Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)","volume":"8","author":"Baptista","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2024.117469_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/dkx351","article-title":"Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms","volume":"73","author":"Dingsdag","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.biopha.2024.117469_bib28","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1021\/acsinfecdis.3c00415","article-title":"Nitric Oxide-Induced Morphological Changes to Bacteria","volume":"9","author":"Nguyen","year":"2023","journal-title":"ACS Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2024.117469_bib29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/1574-6976.12026","article-title":"Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond","volume":"37","author":"Vatansever","year":"2013","journal-title":"FEMS Microbiol Rev."},{"key":"10.1016\/j.biopha.2024.117469_bib30","first-page":"319","article-title":"Global adjustment of microbial physiology during free radical stress","author":"Pomposiello","year":"2002","journal-title":"Adv. Micro Physiol. 46"},{"issue":"8016","key":"10.1016\/j.biopha.2024.117469_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07502-0","article-title":"A Gram-negative-selective antibiotic that spares the gut microbiome","volume":"630","author":"Mu\u00f1oz","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2024.117469_bib32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1208\/s12249-015-0350-9","article-title":"Colon-targeted oral drug delivery systems: design trends and approaches","volume":"16","author":"Amidon","year":"2015","journal-title":"AAPS PharmSciTech"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:16:26Z","timestamp":1773969386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224013556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"alternative-id":["S0753332224013556"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117469","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and preclinical evaluation of MMV676558 as a promising therapeutic candidate against Clostridioides difficile","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117469"}}